Anyplex™ II MTB/MDR Detection
Simultaneous detection of MTB and 25 mutations associated with MDR-TB using real-time PCR
Anyplex™II MTB/MDR Detection simultaneously detects and identifies Mycobacterium tuberculosis (MTB) and 25 mutations associated with MDR-TB. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.
FEATURES
Multiplex real-time PCR
Simultaneous detection of Mycobacterium tuberculosis and 25 mutations associated with MDR-TB
UDG system
Utilization of the UDG system to prevent carry-over contamination
Wide range of specimens
Wide range of applicable specimens
Automatic data analyzer
Automated data interpretation and LIS interlocking with Seegene Viewer
Wild-type Control
WTC (Wild-type Control) and Internal Control (IC) for assay validity
Prediction of antibiotic resistance
Detection and identification of mutations associated antibiotic resistance for appropriate infection control
Fast treatment decision
Fast treatment decision by simultaneous screening and subtyping
Powerful performance with unique technology
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies